Search Results
Aug 10, 2025, 22:11 ET Coalax Lancer300 Empowers Solo Creators with Modular Gear and Patented Magic Arm
content creation. Moreover, the Lancer300's design goes beyond pure functionality. Drawing visual inspiration from iconic Western sci-fi and gaming culture such as Death Stranding, Helldivers, and Star Wars, the Lancer300 doesn't just perform like professional gear. It looks like it
More news about: COALAX TECH INC.
Aug 08, 2025, 16:22 ET The Next Gold Boom May Not Be in Bullion--It's in the Miners
Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific
More news about: USA News Group
Aug 08, 2025, 06:30 ET Polybutylene Adipate Terephthalate Market worth $2.76 billion by 2030 - Exclusive Report by MarketsandMarkets™
companies in this market include BASF SE (Germany), Chang Chun Group (China), Kingfa Sci. & Tech. Co., Ltd. (China), Novamont S.p.A. (Italy), GO YEN CHEMICAL INDUSTRIAL
More news about: MarketsandMarkets
Aug 07, 2025, 11:07 ET Smilegate veröffentlicht das AAA-Open-World-Spiel von Absurd Ventures, das im Universum von A BETTER PARADISE spielt
bekannt gegeben, einen Vertrag mit Absurd Ventures von Dan Houser unterzeichnet zu haben, um das kommende AAA, Open-World, Sci-Fi-Action-Adventure-Spiel des Studios zu veröffentlichen, das in dem faszinierenden Universum von A BETTER PARADISE spielt. Die Partnerschaft folgt auf
More news about: Smilegate
Aug 07, 2025, 08:40 ET Sebela Pharmaceuticals® Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results
Izat E. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010
More news about: Sebela Pharmaceuticals
Aug 07, 2025, 06:25 ET Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
Kobilka, & K.W. Sloop, Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist, Proc. Natl. Acad. Sci. U.S.A. 117 (47) 29959-29967,
More news about: Eli Lilly and Company
Aug 06, 2025, 12:12 ET SERVICE CORPORATION INTERNATIONAL DECLARES QUARTERLY CASH DIVIDEND
HOUSTON, Aug. 6, 2025 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors
More news about: Service Corporation International
Aug 06, 2025, 09:00 ET Smilegate to Publish Absurd Ventures' AAA Open-World Game Set in the A BETTER PARADISE Universe
has signed an agreement with Dan Houser's Absurd Ventures to globally publish the studio's upcoming AAA, open-world, sci-fi action-adventure game, set in its mind-bending A BETTER PARADISE universe. The partnership follows Smilegate's strategic investment in Absurd Ventures,
More news about: Smilegate
Aug 06, 2025, 09:00 ET Smilegate to Publish Absurd Ventures' AAA Open-World Game Set in the A BETTER PARADISE Universe
has signed an agreement with Dan Houser's Absurd Ventures to globally publish the studio's upcoming AAA, open-world, sci-fi action-adventure game, set in its mind-bending A BETTER PARADISE universe. The partnership follows Smilegate's strategic investment in Absurd Ventures,
More news about: Smilegate
Aug 05, 2025, 05:14 ET World Intelligent Vehicle Conference 2025 Successfully Concludes
Innovation Competition, Business Investigation of Chongqing Intelligent Vehicle Ecosystem, Experience of Chongqing Intelligent Driving, and Exhibition of Sci-Tech Innovation Achievements in Intelligent Vehicle. From brainstorming and strategy discussion to achievement exhibition, followed by resource matchmaking
More news about: Asia Digital Group
Aug 01, 2025, 13:36 ET BOAT ROCKER STUDIOS COMPLETES MANAGEMENT BUYOUT, BEGINS NEXT CHAPTER AS INDEPENDENT PRIVATE COMPANY
Brooke Shields (Hulu), Downey's Dream Cars (Max), BS High (HBO), Orphan Black (BBC AMERICA, CTV Sci-Fi Channel), Billie Eilish: The World's a Little Blurry (Apple TV+), The Next Step (BBC, Corus, CBC), Daniel Spellbound (Netflix),
More news about: Boat Rocker Studios
Jul 31, 2025, 10:18 ET FROM FICTION TO FORTUNE: HOLLYWOOD'S MOST LEGENDARY PROPS STAR IN $10 MILLION AUCTION SPECTACLE
PUBLIC AUCTION, WITH A PRE-SALE ESTIMATE OF $250,000 – $500,000. - A STANDOUT SCI-FI PROP - THE LIGHT-UP CLOSE-UP NEURALYZER FROM MEN IN BLACK (1997), USED BY AGENTS J (WILL SMITH) AND K (
More news about: Propstore
Jul 30, 2025, 16:15 ET SERVICE CORPORATION INTERNATIONAL ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS, CONFIRMS 2025 EARNINGS PER SHARE GUIDANCE AND RAISES 2025 CASH FLOW GUIDANCE
HOUSTON, July 30, 2025 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today reported results for the second quarter
More news about: Service Corporation International
Jul 30, 2025, 11:00 ET Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 09:00 ET New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 08:07 ET Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 04:22 ET The Future is Here: Embodied Intelligent Robots
Sci-tech innovation is the core element for developing new quality productive forces. In China today, such productive forces are undergoing robust development, as evidenced by a constant stream of sci-tech innovation achievements.
More news about: en.qstheory.cn
Jul 29, 2025, 10:30 ET AWARD-WINNING GEM® PREMIER™ 7000 with iQM®3 EXPANDS COMMERCIALIZATION TO EUROPE
doi:10.1515/CCLM.2009.132.Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48(3):143–153. doi:10.3109/10408363.2011.600228.O'Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis
More news about: Werfen
Jul 29, 2025, 04:00 ET DealMakerInsider.com Publishes a New White Paper for M&A Advisors on Reframing Sell-Side Qualification in Tech
in future liabilities for you and your brokerage." Art Howarth holds a Bachelor of Computer Science (B. Comp Sci), from the faculty of Engineering & Computer Science at Concordia University. In this article, he shares expert insights on how to improve the qualification
More news about: M&A Source
Jul 28, 2025, 09:10 ET XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury
first "off-the-shelf", allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological disorders, specifically spinal cord injury (SCI) – has commenced. The clinical trial initiation meeting was held at The Third Affiliated Hospital of Sun Yat-sen University
More news about: XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd.
Jul 25, 2025, 03:42 ET Humanoid Robot Industry Chain Matchmaking Event Held at 3rd CISCE
of China Council for the Promotion of International Trade (CCPIT), highlighted Hubei's strategic location, rich sci-tech resources, innovation ecosystem, and openness. He noted the province's rapid progress in humanoid robotics, spanning smart manufacturing, core component
More news about: China International Supply Chain Expo
Jul 25, 2025, 03:18 ET Humanoid Robot Industry Chain Matchmaking Event Held at 3rd CISCE
of China Council for the Promotion of International Trade (CCPIT), highlighted Hubei's strategic location, rich sci-tech resources, innovation ecosystem, and openness. He noted the province's rapid progress in humanoid robotics, spanning smart manufacturing, core component
More news about: China International Supply Chain Expo
Jul 23, 2025, 06:50 ET BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
).ii Woodley, W. D. et al. Clinical Evaluation of an Investigational 5ml Wearable Injector in Healthy Human Subjects. Clin Transl Sci. 2021 May;14(3):859-869. doi.org/10.1111/cts.12946.iii Pharma filled and assemblediv Mordor Intelligence (2025).
More news about: BD (Becton, Dickinson and Company)
Jul 22, 2025, 13:48 ET Newly Published Research Shows Groundbreaking Joint Treatment Changes the Course of Dog Arthritis Management
al. Evidence of osteoarthritis disease modification with a Sn-117m microparticle device: a review and validation in mammalian models. Front. Vet. Sci. 2-25;12:1-13 doi: 10.3389/fvets.2025.1621296.Aulakh KS, Lopez MJ, Hudson C, et al. Prospective Clinical Evaluation of Intra-Articular Injection
More news about: Synovetin OA
Jul 21, 2025, 19:30 ET Eisai to Present Four-Year Efficacy and Safety Data on Continuous Treatment with Lecanemab at The Alzheimer’s Association International Conference
10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.U.S. Food and Drug Administration. 2023. FDA Converts Novel
More news about: Eisai Inc.